# Alnylam Pharmaceuticals and Agilent Technologies sign manufacturing services agreement

Alnylam Pharmaceuticals and Agilent Technologies entered a manufacturing services agreement for the supply of patisiran drug substance by Agilent. The initial term is 5 years, subject to automatic renewal for 2-year terms.

- Type: Contract
- Announced: 2018-04-04
- Status: announced
- Products: patisiran drug substance, active pharmaceutical ingredients
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Agilent Technologies](https://endata.com/companies/1947.md) (supplier)
- [Alnylam Pharmaceuticals](https://endata.com/companies/7063.md) (customer)

## Sources

- [reuters.com](https://www.reuters.com/article/business/alnylam-pharma-co-agilent-technologies-entered-manufacturing-services-agreement-idUSFWN1RG0TJ/), 2018-04-03: "Pursuant to deal, Agilent has agreed to manufacture, supply to co, active pharmaceutical ingredients required for patisiran for commercial sale."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.